Matches in Wikidata for { <http://www.wikidata.org/entity/Q80123055> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- Q80123055 description "article scientifique (publié 2007)" @default.
- Q80123055 description "artikull shkencor i botuar më 01 janar 2007" @default.
- Q80123055 description "artículu científicu espublizáu en xineru de 2007" @default.
- Q80123055 description "im Jahr 2007 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80123055 description "scientific article published on 01 January 2007" @default.
- Q80123055 description "wetenschappelijk artikel" @default.
- Q80123055 description "наукова стаття, опублікована в січні 2007" @default.
- Q80123055 name "[The influence of CYP2C9 genetic polymorphism on the pharmacokinetics and pharmacodynamics of warfarin in patients with constant atrial fibrillation]" @default.
- Q80123055 name "[The influence of CYP2C9 genetic polymorphism on the pharmacokinetics and pharmacodynamics of warfarin in patients with constant atrial fibrillation]" @default.
- Q80123055 name "[The influence of CYP2C9 genetic polymorphism on the pharmacokinetics and pharmacodynamics of warfarin in patients with constant atrial fibrillation]" @default.
- Q80123055 type Item @default.
- Q80123055 label "[The influence of CYP2C9 genetic polymorphism on the pharmacokinetics and pharmacodynamics of warfarin in patients with constant atrial fibrillation]" @default.
- Q80123055 label "[The influence of CYP2C9 genetic polymorphism on the pharmacokinetics and pharmacodynamics of warfarin in patients with constant atrial fibrillation]" @default.
- Q80123055 label "[The influence of CYP2C9 genetic polymorphism on the pharmacokinetics and pharmacodynamics of warfarin in patients with constant atrial fibrillation]" @default.
- Q80123055 prefLabel "[The influence of CYP2C9 genetic polymorphism on the pharmacokinetics and pharmacodynamics of warfarin in patients with constant atrial fibrillation]" @default.
- Q80123055 prefLabel "[The influence of CYP2C9 genetic polymorphism on the pharmacokinetics and pharmacodynamics of warfarin in patients with constant atrial fibrillation]" @default.
- Q80123055 prefLabel "[The influence of CYP2C9 genetic polymorphism on the pharmacokinetics and pharmacodynamics of warfarin in patients with constant atrial fibrillation]" @default.
- Q80123055 P1433 Q80123055-F168B268-2565-4C29-AD2A-569D3DA67936 @default.
- Q80123055 P1476 Q80123055-41997FD9-57CF-4129-8271-A6DEA72AA7AC @default.
- Q80123055 P2093 Q80123055-03133CDA-389A-4DEA-B507-934661E39C2B @default.
- Q80123055 P2093 Q80123055-3708F14E-4A7E-4A19-8138-51BC7ADAA5D1 @default.
- Q80123055 P2093 Q80123055-4AA62DBF-FF23-4273-ABEF-FCA4056214B9 @default.
- Q80123055 P2093 Q80123055-5F3C2EDC-B218-4E4D-867A-F1B2F974F781 @default.
- Q80123055 P2093 Q80123055-68AE1449-2C2B-455A-B16D-5438F8AAE2BE @default.
- Q80123055 P2093 Q80123055-7874DA84-2D15-4B92-894C-07508F54585B @default.
- Q80123055 P2093 Q80123055-82643528-A986-4E29-B889-F9CB28E01071 @default.
- Q80123055 P2093 Q80123055-9E1C34EF-B13E-4FFA-9E1A-FA96F9ABB6C0 @default.
- Q80123055 P2093 Q80123055-D8A3C75F-6AD4-4AAA-B874-1C657CBB21BF @default.
- Q80123055 P304 Q80123055-DBC5FB6D-1546-45A6-97F6-67D50ED9B1D4 @default.
- Q80123055 P31 Q80123055-9EE5F3E6-4481-49A3-AD00-81F68A0830BD @default.
- Q80123055 P433 Q80123055-3DEA8AF6-05E5-44A5-AE70-2831480D6F32 @default.
- Q80123055 P478 Q80123055-A1C55A68-EA3C-4BEF-87AF-39EA4A842A8D @default.
- Q80123055 P577 Q80123055-F4FD7886-EAF1-4D7F-81DA-E6D7BAA9B813 @default.
- Q80123055 P698 Q80123055-D48E8579-9E96-4E8F-B364-D9AEE4FD3682 @default.
- Q80123055 P921 Q80123055-1D765B27-E118-4DFA-A592-07063870770D @default.
- Q80123055 P921 Q80123055-1E5A04A9-6D7D-405A-BC35-08B4481A28D9 @default.
- Q80123055 P921 Q80123055-3B3D2C19-02C3-4C43-B47D-B1CD006E72B3 @default.
- Q80123055 P921 Q80123055-CE34A1E0-49B6-488F-ADAA-91200FD3C2E4 @default.
- Q80123055 P698 17419358 @default.
- Q80123055 P1433 Q27711850 @default.
- Q80123055 P1476 "[The influence of CYP2C9 genetic polymorphism on the pharmacokinetics and pharmacodynamics of warfarin in patients with constant atrial fibrillation]" @default.
- Q80123055 P2093 "Bulytova IuM" @default.
- Q80123055 P2093 "Dobrovol'skiĭ AB" @default.
- Q80123055 P2093 "Ignat'ev IV" @default.
- Q80123055 P2093 "Kropacheva ES" @default.
- Q80123055 P2093 "Kukes VG" @default.
- Q80123055 P2093 "Mikheeva IuA" @default.
- Q80123055 P2093 "Panchenko EP" @default.
- Q80123055 P2093 "Ramenskaia GV" @default.
- Q80123055 P2093 "Sychev DA" @default.
- Q80123055 P304 "57-60" @default.
- Q80123055 P31 Q13442814 @default.
- Q80123055 P433 "1" @default.
- Q80123055 P478 "85" @default.
- Q80123055 P577 "2007-01-01T00:00:00Z" @default.
- Q80123055 P698 "17419358" @default.
- Q80123055 P921 Q323936 @default.
- Q80123055 P921 Q407431 @default.
- Q80123055 P921 Q725307 @default.
- Q80123055 P921 Q815819 @default.